Sign Out
Olopatadine is an antiallergic/antihistamine agent and, although administered topically, is absorbed systematically. If signs of serious reactions or hypersensitivity occur, discontinue the use of this treatment.
Olopatadine contains Benzalkonium chloride which may cause eye irritation.
Benzalkonium chloride has also been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy.
Close monitoring is required with frequent or prolonged use in dry eye patients, or in conditions where the cornea is compromised.
Contact lenses: Benzalkonium is known to discolour soft contact lenses. Avoid contact with soft contact lenses.
Patients should be instructed to remove contact lenses prior to administration of the eye drop and wait at least 15 minutes after instillation before re-inserting contact lenses.
Continue with Google